Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
Clinical trial NCT04954859 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04954859
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2029-01-24
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.